KEGG   DRUG: Dorocubicel
Entry
D13157                      Drug                                   
Name
Dorocubicel (USAN/INN);
Zemcelpro (TN)
Remark
ATC code: B05AX04
Efficacy
Antineoplastic, Immunomodulator
  Type
Cellular therapy product
Comment
allogeneic human umbilical cord blood derived CD34+ hematopoietic stem and progenitor cells
Treatment of haematological malignancies.
Target
CD34 [HSA:947] [KO:K06474]
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 B BLOOD AND BLOOD FORMING ORGANS
  B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
   B05A BLOOD AND RELATED PRODUCTS
    B05AX Other blood products
     B05AX04 Stem cells from umbilical cord blood
      D13157  Dorocubicel (USAN/INN)
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Other cell surface molecules
   CD molecules
    CD34
     D13157  Dorocubicel (USAN/INN)
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D13157
 Cellular and gene therapy products
  D13157
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D13157
Other DBs
PubChem: 518520877
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system